澳大利亚全基因组关联研究证实CCDC26区域变异与成人胶质瘤女性风险较高相关
该研究对560例欧洲血统胶质瘤病例和2237例对照的7573692个单核苷酸多态性(SNP)进行全基因组关联分析,按亚型和性别评估关联。
要点
- 8q24.21 CCDC26区域性别差异重复验证(P=.0024),两性关联均名义显著(P<.05)。
- 研究支持女性该区域风险关联更强,强调按性别分析胶质瘤GWAS的重要性。
核心结论
- 研究支持8q24.21 CCDC26区域女性风险关联更强,并强调按性别分析胶质瘤GWAS的重要性。
研究设计与样本
- 澳大利亚胶质瘤基因组与临床结局(AGOG)联盟的全基因组关联研究,纳入560例欧洲血统胶质瘤病例和2237例对照,分析7573692个SNP。
- 病例分为胶质母细胞瘤、非胶质母细胞瘤、星形细胞瘤或少突胶质细胞瘤,采用逻辑回归按亚型和性别评估SNP与胶质瘤风险的关联。
主要发现
- 重复了既往报道的2q33.3 C2orf80、2q37.3 D2HGDH、5p15.33 TERT、7p11.2 EGFR、8q24.21 CCDC26、9p21.3 CDKN2BAS、11q21 MAML2、11q23.3 PHLDB1、15q24.2 ETFA、16p13.3 RHBDF1、16p13.3 LMF1、17p13.1 TP53、20q13.33 RTEL和20q13.33 GMEB2区域胶质瘤风险关联(P<.05)。
- 重复了既往报道的8q24.21 CCDC26区域性别差异(P=.0024),该关联在两性中均名义显著(P<.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma accounts for approximately 80% of malignant adult brain cancer and its most common subtype, glioblastoma, has one of the lowest 5-year cancer survivals. Fifty risk-associated variants within 34 glioma genetic risk regions have been found by genome-wide association studies (GWAS) with a sex difference reported for 8q24.21 region. We conducted an Australian GWAS by glioma subtype and sex. METHODS: We analyzed genome-wide data from the Australian Genomics and Clinical Outcomes of Glioma (AGOG) consortium for 7 573 692 single nucleotide polymorphisms (SNPs) for 560 glioma cases and 2237 controls of European ancestry. Cases were classified as glioblastoma, non-glioblastoma, astrocytoma or oligodendroglioma. Logistic regression analysis was used to assess the associations of SNPs with glioma risk by subtype and by sex. RESULTS: We replicated the previously reported glioma risk associations in the regions of 2q33.3 C2orf80, 2q37.3 D2HGDH, 5p15.33 TERT, 7p11.2 EGFR, 8q24.21 CCDC26, 9p21.3 CDKN2BAS, 11q21 MAML2, 11q23.3 PHLDB1, 15q24.2 ETFA, 16p13.3 RHBDF1, 16p13.3 LMF1, 17p13.1 TP53, 20q13.33 RTEL, and 20q13.33 GMEB2 (P < .05). We also replicated the previously reported sex difference at 8q24.21 CCDC26 (P = .0024) with the association being nominally significant for both sexes (P < .05). CONCLUSIONS: Our study supports a stronger female risk association for the region 8q24.21 CCDC26 and highlights the importance of analyzing glioma GWAS by sex. A better understanding of sex differences could provide biological insight into the cause of glioma with implications for prevention, risk prediction and treatment.
引用
- Alpen K, Vajdic CM, MacInnis RJ, et al. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro Oncol. 2023. PMID: 36541697. doi:10.1093/neuonc/noac279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。